Category Specific RSS

Samantha Freidin

Imugene partners with multi billion dollar global pharma company, Merck & Co for new trial

Since securing a European patent for their proprietary cancer vaccine HER-Vaxx, Imugene (ASX: IMU) have been busy. The Company has…

4 years ago

Neuren Pharmaceuticals gains approval for trial in yet another neurodevelopmental disorder

The complexity of the human body never ceases to amaze me. So many systems need to work together to carry…

4 years ago

Live Verdure keen to tap into the beauty market with hemp based skincare line in development

The Australian skin care products market is forecast to reach over $300 million by 2025.  That’s a lot of moisturiser...…

4 years ago

Silver linings of conflict, defence companies gain momentum

I’m not sure about you, but I’m getting a bit sick of living in a VERY interesting part of next…

4 years ago

Out-the-box thinkers are just what the myelofibrosis treatment market needs

The pharmaceutical industry is an incredibly competitive space with new drug discoveries cropping up all the time, giving hope that…

5 years ago